Cationic Lipid‐based Intracellular Delivery of Bacterial Effectors for Rewiring Malignant Cell Signaling
Authors:
- 16 July 2020
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 132 (41) , 18243-18250
Abstract
The abundance of bacterial effectors have inspired us to explore their potential in rewiring malignant cell signaling. Their incapability for entering cells, however, hinders such application. Herein we developed a cationic lipid‐based high throughput library screening platform for effective intracellular delivery of bacterial effectors. As the misregulated MAPK signaling is a hallmark of many types of cancer, we turned to the Shigella effector OspF which irreversibly inactivates ERK, the terminal component of MAPK cascade. We created a function‐based screening assay to obtain AMPA‐O16B lipid nanoparticles for effective OspF intracellular delivery, which inhibited the malignant MAPK signaling and tumor growth in vitro and in vivo. Furthermore, the optimized lipid nanoparticle formulation can deliver OspF to modulate the immunosuppressive responses in macrophages. Our work is a general strategy to explore the therapeutic potentials of naturally evolved bacterial effectors.Keywords
This publication has 51 references indexed in Scilit:
- Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cellsNature, 2012
- Tipping the balance by manipulating post-translational modificationsCurrent Opinion in Microbiology, 2010
- The regulation of IL-10 production by immune cellsNature Reviews Immunology, 2010
- MEK1 mutations confer resistance to MEK and B-RAF inhibitionProceedings of the National Academy of Sciences, 2009
- ERK dimers and scaffold proteins: Unexpected partners for a forgotten (cytoplasmic) taskCell Cycle, 2009
- Structural Insights into the Enzymatic Mechanism of the Pathogenic MAPK Phosphothreonine LyaseMolecular Cell, 2007
- Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancerOncogene, 2007
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapyEuropean Journal of Cancer, 2006
- Mutations of the BRAF gene in human cancerNature, 2002
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002